MCID: CVR006
MIFTS: 55

Cavernous Hemangioma

Categories: Blood diseases, Neuronal diseases

Aliases & Classifications for Cavernous Hemangioma

MalaCards integrated aliases for Cavernous Hemangioma:

Name: Cavernous Hemangioma 12 77 30 6 15 17
Hemangioma, Cavernous 45 74
Cavernous Haemangioma 12
Cavernomas 55
Cavernoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:483
MeSH 45 D006392
NCIt 51 C3086
ICD10 34 D18.0
UMLS 74 C0018920

Summaries for Cavernous Hemangioma

NINDS : 55 Cerebral cavernous malformations (CCMs) are vascular lesions comprised of clusters of tightly packed, abnormally thin-walled small blood vessels (capillaries) that displace normal neurological tissue in the brain or spinal cord. The vessels are filled with slow-moving or stagnant blood that is usually clotted or in a state of decomposition. Cavernous malformations can occur in the brain, spinal cord, and some other body regions. In the brain and spinal cord these cavernous lesions are quite fragile and are prone to bleeding, causing hemorrhagic strokes (bleeding into the brain), seizures, and neurological deficits. CCMs can range in size from a few fractions of an inch to several inches in diameter, depending on the number of blood vessels involved. Some people develop multiple lesions while others never experience related medical problems. Hereditary forms of CCM are caused by mutations in one of three CCM disease genes: CCM1, CCM2, and CCM3. A large population with hereditary CCM disease is found in New Mexico and the Southwestern United States, in which the disease is caused by mutations in the gene CCM1 (or KRIT1).

MalaCards based summary : Cavernous Hemangioma, also known as hemangioma, cavernous, is related to cerebral cavernous malformations and cerebral cavernous malformations 3. An important gene associated with Cavernous Hemangioma is KRIT1 (KRIT1 Ankyrin Repeat Containing), and among its related pathways/superpathways are p70S6K Signaling and MAPK signaling pathway. The drugs Strawberry and Timolol have been mentioned in the context of this disorder. Affiliated tissues include liver, brain and bone, and related phenotypes are cardiovascular system and cellular

Wikipedia : 77 Cavernous hemangioma, also called cavernous angioma, cavernoma, or cerebral cavernous malformation (CCM)... more...

Related Diseases for Cavernous Hemangioma

Diseases related to Cavernous Hemangioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 347)
# Related Disease Score Top Affiliating Genes
1 cerebral cavernous malformations 33.9 CCM2 KDR KRIT1 PDCD10
2 cerebral cavernous malformations 3 32.5 CCM2 KRIT1 PDCD10
3 cerebral cavernous malformations 2 32.4 CCM2 KRIT1 PDCD10
4 hemangioma 31.7 CCM2 FGF2 KDR KRIT1 NKX2-1 PECAM1
5 hemangioma of liver 31.0 F2 KRIT1
6 secretory meningioma 30.9 MUC1 VIM
7 klippel-trenaunay-weber syndrome 30.8 CCM2 KRIT1 PDCD10
8 cavernous malformation 30.8 CCM2 KRIT1 PDCD10
9 meningioma, familial 30.7 MKI67 PDCD10 SYP
10 human venous malformation 30.6 CCM2 KRIT1 PDCD10
11 hemangioendothelioma 30.5 KDR PECAM1
12 neurilemmoma 30.4 KIT PDGFRA VIM
13 angiosarcoma 30.1 KDR KIT MUC1 PECAM1 VIM
14 leiomyoma 30.1 KIT MKI67 VIM
15 teratoma 29.9 KIT NKX2-1 SYP
16 angiomyoma 29.8 KIT MB SYP
17 ependymoma 29.8 MKI67 MUC1 SYP VIM
18 bone marrow cancer 29.6 FGF2 KDR KIT PDGFRA
19 sarcoma, synovial 29.5 KIT KRT19 MUC1 VIM
20 neurofibroma 29.4 KIT MUC1 PDGFRA SYP
21 adenoid cystic carcinoma 28.8 KIT KRT19 MKI67 MUC1 TP63 VIM
22 renal cell carcinoma, nonpapillary 28.8 FGF2 KDR KIT KRT19 MUC1 NKX2-1
23 cavernous hemangioma of colon 12.5
24 cavernous hemangioma of face 12.4
25 diffuse cavernous hemangioma of the rectum 12.4
26 cavernous hemangioma of orbit 12.4
27 supraumbilical midabdominal raphe and facial cavernous hemangiomas 12.4
28 multiple enchondromatosis, maffucci type 12.0
29 intracranial cavernous angioma 11.6
30 capillary hemangioma 11.6
31 dermal unilateral segmental cavernous angioma 11.5
32 cerebral cavernous malformation, familial 11.5
33 hemangiomas, cavernous, of face and supraumbilical midline raphe 11.3
34 hepatocellular carcinoma 10.4
35 spinal meningioma 10.4
36 vascular hemostatic disease 10.4 CCM2 F2 KRIT1
37 venous malformations, multiple cutaneous and mucosal 10.4 CCM2 KRIT1 PDCD10
38 mast-cell sarcoma 10.3 KIT VIM
39 acinar cell cystadenocarcinoma 10.3 MKI67 SYP
40 radiation proctitis 10.3 FGF2 KDR PECAM1
41 primary hepatic neuroendocrine carcinoma 10.3 SYP VIM
42 mesenteric vascular occlusion 10.3 F2 MB
43 embryonal sarcoma 10.3 KIT MKI67 VIM
44 small cell carcinoma of the bladder 10.3 NKX2-1 SYP
45 senile angioma 10.3 KDR KIT VIM
46 regional odontodysplasia 10.3 KRT19 VIM
47 sm-ahnmd 10.2 KIT PDGFRA
48 malignant peritoneal mesothelioma 10.2 MUC1 VIM
49 cutaneous ganglioneuroma 10.2 KIT SYP
50 papillary adenoma 10.2 NKX2-1 VIM

Graphical network of the top 20 diseases related to Cavernous Hemangioma:



Diseases related to Cavernous Hemangioma

Symptoms & Phenotypes for Cavernous Hemangioma

MGI Mouse Phenotypes related to Cavernous Hemangioma:

47 (show all 20)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.49 CCM2 F2 FGF2 HSPA5 KDR KIT
2 cellular MP:0005384 10.42 CCM2 FGF2 HSPA5 KDR KIT KRT19
3 behavior/neurological MP:0005386 10.37 CCM2 F2 FGF2 KDR KIT NKX2-1
4 embryo MP:0005380 10.36 CCM2 F2 HSPA5 KDR KIT KRIT1
5 homeostasis/metabolism MP:0005376 10.36 CCM2 F2 FGF2 HSPA5 KDR KIT
6 growth/size/body region MP:0005378 10.35 CCM2 F2 HSPA5 KDR KIT KRIT1
7 mortality/aging MP:0010768 10.35 CCM2 F2 FGF2 HSPA5 KDR KIT
8 hematopoietic system MP:0005397 10.26 CCM2 F2 FGF2 KDR KIT MB
9 nervous system MP:0003631 10.25 CCM2 F2 FGF2 HSPA5 KDR KIT
10 integument MP:0010771 10.24 CCM2 F2 HSPA5 KDR KIT KRIT1
11 muscle MP:0005369 10.23 CCM2 FGF2 KDR KIT KRIT1 MB
12 digestive/alimentary MP:0005381 10.21 F2 HSPA5 KIT KRT19 NKX2-1 PDGFRA
13 normal MP:0002873 10.13 CCM2 F2 HBG2 HSPA5 KDR KIT
14 craniofacial MP:0005382 10.11 CCM2 HSPA5 KDR KIT KRIT1 PDGFRA
15 neoplasm MP:0002006 10.09 FGF2 HSPA5 KIT KRIT1 KRT19 NKX2-1
16 no phenotypic analysis MP:0003012 9.97 HBG2 KDR KIT KRT19 MKI67 NKX2-1
17 reproductive system MP:0005389 9.91 F2 FGF2 HSPA5 KIT KRT19 NKX2-1
18 respiratory system MP:0005388 9.85 F2 HSPA5 KDR KIT MB NKX2-1
19 skeleton MP:0005390 9.65 F2 FGF2 KDR KIT KRT19 NKX2-1
20 vision/eye MP:0005391 9.28 CCM2 FGF2 KDR KIT KRIT1 PDCD10

Drugs & Therapeutics for Cavernous Hemangioma

Drugs for Cavernous Hemangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 28)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Strawberry Approved Phase 2
2
Timolol Approved Phase 2 26839-75-8 5478 33624
3
Atorvastatin Approved Phase 1, Phase 2 134523-00-5 60823
4
Propranolol Approved, Investigational Phase 2,Phase 1 525-66-6 4946
5
Maleic acid Experimental, Investigational Phase 2 110-17-8, 110-16-7 444972
6 Adrenergic Antagonists Phase 2,Phase 1
7 Anti-Arrhythmia Agents Phase 2,Phase 1
8 Antihypertensive Agents Phase 2,Phase 1
9 Adrenergic Agents Phase 2,Phase 1
10 Neurotransmitter Agents Phase 2,Phase 1
11 Adrenergic beta-Antagonists Phase 2,Phase 1
12 Anticholesteremic Agents Phase 1, Phase 2,Early Phase 1
13 Antimetabolites Phase 1, Phase 2,Early Phase 1
14 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 1, Phase 2,Early Phase 1
15 Hypolipidemic Agents Phase 1, Phase 2,Early Phase 1
16 Lipid Regulating Agents Phase 1, Phase 2,Early Phase 1
17 Vasodilator Agents Phase 2,Phase 1
18
Doxycycline Approved, Investigational, Vet_approved Phase 1 564-25-0 54671203
19 Antiparasitic Agents Phase 1
20 Antiprotozoal Agents Phase 1
21 Anti-Bacterial Agents Phase 1
22 Antimalarials Phase 1
23 Anti-Infective Agents Phase 1
24
Simvastatin Approved Early Phase 1 79902-63-9 54454
25 Hematinics Not Applicable
26 Liver Extracts Not Applicable
27 Anticonvulsants
28 Analgesics

Interventional clinical trials:

(show all 15)
# Name Status NCT ID Phase Drugs
1 Effectiveness and Safety of Intense Pulsed Light in Patients With Meibomian Gland Dysfunction Recruiting NCT03518398 Phase 3
2 Topical Timolol Gel for the Treatment of Infantile Hemangiomas Completed NCT02145884 Phase 2 timolol maleate 0.5% gel
3 Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial Recruiting NCT02603328 Phase 1, Phase 2 Atorvastatin
4 Treat_CCM: Propranolol in Cerebral Cavernous Malformation Recruiting NCT03589014 Phase 2 Propranolol
5 Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation Recruiting NCT03474614 Phase 2 Propranolol
6 Influence of MMP on Brain AVM Hemorrhage Completed NCT00783523 Phase 1 Doxycycline or Placebo
7 Oral Propanolol for Surgically Inaccessible Cavernous Malformations Enrolling by invitation NCT03523650 Phase 1 Propranolol Oral Tablet;Placebo Oral Tablet
8 Cerebral Bases Bodily Representations Unknown status NCT02876016 Not Applicable
9 A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver Completed NCT01471080 Not Applicable
10 Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins Completed NCT01764451 Early Phase 1 Simvastatin
11 CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness Recruiting NCT03652181
12 Modifiers of Disease Severity in Cerebral Cavernous Malformations Recruiting NCT01764529
13 A Prospective Study on the Incidence and Related Risk Factors of Infantile Hemangioma in China Recruiting NCT03173352
14 Treatments and Outcomes of Untreated Cerebral Cavernous Malformations in CHina. Recruiting NCT03467295
15 CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study Recruiting NCT02946866

Search NIH Clinical Center for Cavernous Hemangioma

Cochrane evidence based reviews: hemangioma, cavernous

Genetic Tests for Cavernous Hemangioma

Genetic tests related to Cavernous Hemangioma:

# Genetic test Affiliating Genes
1 Cavernous Hemangioma 30

Anatomical Context for Cavernous Hemangioma

MalaCards organs/tissues related to Cavernous Hemangioma:

42
Liver, Brain, Bone, Spinal Cord, Colon, Smooth Muscle, Lung

Publications for Cavernous Hemangioma

Articles related to Cavernous Hemangioma:

(show top 50) (show all 1278)
# Title Authors Year
1
Diffuse cavernous hemangioma of the skull misdiagnosed as skull metastasis in breast cancer patient: one case report and literature review. ( 30803439 )
2019
2
A Giant Cardiac Cavernous Hemangioma Involving the Left Atrial Roof in an Elderly Woman. ( 29459567 )
2019
3
Female Urethral Cavernous Hemangioma, A Rare Entity: Two Case Reports and Review of The Literature. ( 30058065 )
2019
4
Endoscopic Endonasal Resection of Orbital Apex Cavernous Hemangioma: 2-Dimensional Operative Video. ( 30085112 )
2019
5
New Interpretation of Multimodality Fundus Imaging for Retinal Cavernous Hemangioma. ( 30433829 )
2019
6
Endoscope-Assisted Resection of Intramuscular Cavernous Hemangioma Within the Temporal Muscle. ( 30475294 )
2019
7
Commentary: Endoscopic Endonasal Resection of Orbital Apex Cavernous Hemangioma: 2-Dimensional Operative Video. ( 30496482 )
2019
8
Urethral cavernous hemangioma in female: Surgical resection and reconstruction with ventral vaginal graft urethroplasty. ( 30591908 )
2019
9
Surgical treatment of an asymptomatic giant supratentorial cavernous hemangioma. Case report. ( 30616875 )
2019
10
Intrapericardial cavernous hemangioma: an unusual mediastinal tumor! ( 30650037 )
2019
11
Urethral cavernous hemangioma: a highly misdiagnosed disease (a case report of two patients and literature review). ( 30704439 )
2019
12
When one expects a prolapsed lumbar disk and finds a Pure Epidural Spinal Cavernous Hemangioma (PESCH): a "neurosurgical surprise"! ( 30724051 )
2019
13
Development of the international orbital Cavernous Hemangioma Exclusively Endonasal Resection (CHEER) staging system. ( 30809970 )
2019
14
Familial Cavernous Hemangioma. ( 30893269 )
2019
15
A case of retinal cavernous hemangioma analyzed with optical coherence tomography angiography. ( 30900601 )
2019
16
Successful endoscopic submucosal dissection of a large cavernous hemangioma in the colon. ( 30978732 )
2019
17
Radiologic Features with Pathologic Correlation of an Unusual Large Intraosseous Skull Cavernous Hemangioma. ( 30988275 )
2019
18
Atypical presentation of a parietal convexity dural-based cavernous hemangioma: A case report and review of the literature. ( 31009776 )
2019
19
Cavernous hemangioma of the rib mimicking a chondrosarcoma: Diagnostic value of delayed phase MRI. ( 31047838 )
2019
20
Intranodal capillary-cavernous hemangioma: Report of a very rare case. ( 31105947 )
2019
21
Cavernous hemangioma in unusual location: pterygopalatine fossa. ( 27117893 )
2019
22
Intrasellar cavernous hemangioma presenting as pituitary adenoma: A report of two cases and review of the literature. ( 29189199 )
2018
23
Spinal epidural cavernous hemangioma: case report. ( 28637111 )
2018
24
Teaching Neuroimages: "Filling out" in Cavernous Hemangioma of the Cavernous Sinus. ( 28721610 )
2018
25
Dural Penetration of Cavernous Hemangioma on Skull: Uncommon Clinical Presentation. ( 29109062 )
2018
26
Optic Nerve Meningioma Mimicking Cavernous Hemangioma. ( 29191527 )
2018
27
Nasal Septal Cavernous Hemangioma. ( 29215446 )
2018
28
Spinal Epidural Cavernous Hemangioma: A Clinical Series of 7 Patients. ( 29248776 )
2018
29
Endoscopic management of Atypical sellar cavernous hemangioma: A case report and review of the literature. ( 29248833 )
2018
30
Giant Cavernous Hemangioma of the Adrenal Gland in an Elderly Patient. ( 29279502 )
2018
31
In Response to the Letter to the Editor Regarding "Optic Nerve Meningioma Mimicking Cavernous Hemangioma". ( 29288857 )
2018
32
Orbital Cavernous Hemangioma Causing Spontaneous Compressive Hemorrhage. ( 29419596 )
2018
33
A new surgical technique for excision of orbital cavernous hemangioma: a 15-year experience. ( 29442536 )
2018
34
Analysis of the characteristics of optical coherence tomography angiography for retinal cavernous hemangioma: A case report. ( 29443780 )
2018
35
Letter to the Editor Regarding "Optic Nerve Meningioma Mimicking Cavernous Hemangioma". ( 29499604 )
2018
36
RETINAL CAVERNOUS HEMANGIOMA WITH INTRALESIONAL PHLEBOLITHS. ( 29505489 )
2018
37
Gastric Cavernous Hemangioma Resected by Endoscopic Submucosal Dissection. ( 29607958 )
2018
38
Multidisciplinary management of an intra-sellar cavernous hemangioma: Case report and review of the literature. ( 29622503 )
2018
39
Cavernous hemangioma of the interatrial septum. ( 29629515 )
2018
40
Venous Malformation (Cavernous Hemangioma) of the Supraorbital Nerve. ( 29682072 )
2018
41
Sudden spinal hemorrhage in a pediatric case with total body irradiation-induced cavernous hemangioma. ( 29797651 )
2018
42
Giant Colonic Cavernous Hemangioma Causing Hematochezia in a 14-Year-Old Boy. ( 29806995 )
2018
43
Cavernous Hemangioma Between the Elastomer and Fibrous Capsule of a Breast Implant. ( 29872905 )
2018
44
Multifocal cavernous hemangioma of the jugular foramen: a rare skull base vascular malformation. ( 29979118 )
2018
45
Cavernous hemangioma of the thymus: A case report and review of the literature. ( 30045327 )
2018
46
Testicular cavernous hemangioma associated with testicular torsion - case report and review of literature. ( 30055478 )
2018
47
A case of reversible cerebral vasoconstriction syndrome and cavernous hemangioma: just a coincidence? ( 30062645 )
2018
48
TMS-induced motor evoked potential in the preliminary diagnosis of intracranial cavernous hemangioma: A case report. ( 30087033 )
2018
49
Spinal intradural extramedullary cavernous hemangioma. ( 30090980 )
2018
50
Three-dimensional laparoscopy-assisted bowel resection for cavernous hemangioma of the rectum: Report of two cases. ( 30094939 )
2018

Variations for Cavernous Hemangioma

ClinVar genetic disease variations for Cavernous Hemangioma:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 CCM2 NM_031443.3(CCM2): c.354C> G (p.Tyr118Ter) single nucleotide variant Pathogenic rs765548101 GRCh38 Chromosome 7, 45064528: 45064528
2 CCM2 NM_031443.3(CCM2): c.354C> G (p.Tyr118Ter) single nucleotide variant Pathogenic rs765548101 GRCh37 Chromosome 7, 45104127: 45104127
3 PDCD10 NM_145860.1(PDCD10): c.474+5G> A single nucleotide variant Pathogenic/Likely pathogenic rs1553759139 GRCh38 Chromosome 3, 167687610: 167687610
4 PDCD10 NM_145860.1(PDCD10): c.474+5G> A single nucleotide variant Pathogenic/Likely pathogenic rs1553759139 GRCh37 Chromosome 3, 167405398: 167405398
5 KRIT1 NM_004912.4(KRIT1): c.990-1G> A single nucleotide variant Likely pathogenic rs1554518790 GRCh38 Chromosome 7, 92226683: 92226683
6 KRIT1 NM_004912.4(KRIT1): c.990-1G> A single nucleotide variant Likely pathogenic rs1554518790 GRCh37 Chromosome 7, 91855997: 91855997
7 KRIT1 NM_004912.4(KRIT1): c.902C> G (p.Ser301Ter) single nucleotide variant Pathogenic rs1554527169 GRCh38 Chromosome 7, 92234536: 92234536
8 KRIT1 NM_004912.4(KRIT1): c.902C> G (p.Ser301Ter) single nucleotide variant Pathogenic rs1554527169 GRCh37 Chromosome 7, 91863850: 91863850

Expression for Cavernous Hemangioma

Search GEO for disease gene expression data for Cavernous Hemangioma.

Pathways for Cavernous Hemangioma

GO Terms for Cavernous Hemangioma

Biological processes related to Cavernous Hemangioma according to GeneCards Suite gene sharing:

(show all 23)
# Name GO ID Score Top Affiliating Genes
1 cell differentiation GO:0030154 9.9 FGF2 KDR TP63 XBP1
2 cytokine-mediated signaling pathway GO:0019221 9.89 FGF2 KIT MUC1 VIM
3 positive regulation of ERK1 and ERK2 cascade GO:0070374 9.87 FGF2 KDR KIT PDGFRA
4 extracellular matrix organization GO:0030198 9.83 FGF2 KDR PDGFRA PECAM1
5 transmembrane receptor protein tyrosine kinase signaling pathway GO:0007169 9.76 KDR KIT PDGFRA
6 wound healing GO:0042060 9.75 FGF2 PDGFRA PECAM1
7 negative regulation of apoptotic process GO:0043066 9.73 HSPA5 KDR PDCD10 XBP1
8 animal organ morphogenesis GO:0009887 9.71 FGF2 NKX2-1 PDGFRA TP63
9 positive regulation of cell proliferation GO:0008284 9.7 F2 FGF2 KDR KIT PDCD10 PDGFRA
10 positive regulation of MAP kinase activity GO:0043406 9.69 FGF2 KIT PDCD10
11 peptidyl-tyrosine phosphorylation GO:0018108 9.65 KDR KIT PDGFRA
12 positive regulation of Notch signaling pathway GO:0045747 9.63 KIT PDCD10 TP63
13 positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068 9.62 F2 KDR KIT PDGFRA
14 embryonic hemopoiesis GO:0035162 9.61 KDR KIT
15 oxygen transport GO:0015671 9.61 HBG2 MB
16 Leydig cell differentiation GO:0033327 9.56 NKX2-1 PDGFRA
17 ATF6-mediated unfolded protein response GO:0036500 9.55 HSPA5 XBP1
18 negative regulation of platelet activation GO:0010544 9.54 F2 PDGFRA
19 positive regulation of phosphatidylinositol 3-kinase activity GO:0043552 9.54 FGF2 KIT PDGFRA
20 positive regulation of phospholipase C activity GO:0010863 9.43 FGF2 KIT PDGFRA
21 angiogenesis GO:0001525 9.43 FGF2 KDR KRIT1 PDCD10 PECAM1 XBP1
22 positive regulation of cell migration GO:0030335 9.1 HSPA5 KDR KIT PDCD10 PDGFRA XBP1
23 multicellular organism development GO:0007275 10.04 CCM2 F2 FGF2 KDR PDGFRA TP63

Molecular functions related to Cavernous Hemangioma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 9.58 CCM2 F2 FGF2 HBG2 HSPA5 KDR
2 transmembrane receptor protein tyrosine kinase activity GO:0004714 9.43 KDR KIT PDGFRA
3 oxygen carrier activity GO:0005344 9.37 HBG2 MB
4 protein tyrosine kinase activity GO:0004713 9.33 KDR KIT PDGFRA
5 vascular endothelial growth factor-activated receptor activity GO:0005021 9.32 KDR PDGFRA
6 vascular endothelial growth factor binding GO:0038085 8.96 KDR PDGFRA

Sources for Cavernous Hemangioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....